[Reinventing thalidomide under high supervision].
Monneret
C
C
D000014:Abnormalities, Drug-Induced / Q000266:history; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018795:Device Approval; D005260:Female; D049673:History, 20th Century; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000266:history / Q000627:therapeutic use*; D011247:Pregnancy; D013723:Teratogens / Q000266:history; D013792:Thalidomide / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006993:Hypnotics and Sedatives; D013723:Teratogens; D013792:Thalidomide